Galmed Pharmaceuticals
GLMD
#9924
Rank
โ‚น0.38 B
Marketcap
โ‚น254.80
Share price
4.86%
Change (1 day)
-27.86%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2024 (TTM): -โ‚น0.49 Billion

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น0.59 Billion, an increase over its 2022 earnings that were of -โ‚น1.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น0.49 Billion-15.99%
2023 -โ‚น0.59 Billion-61.31%
2022 -โ‚น1.51 Billion-44.97%
2021 -โ‚น2.74 Billion12.85%
2020 -โ‚น2.43 Billion40.61%
2019 -โ‚น1.73 Billion109.19%
2018 -โ‚น0.83 Billion-20.47%
2017 -โ‚น1.04 Billion-27%
2016 -โ‚น1.43 Billion58.6%
2015 -โ‚น0.9 Billion16.7%
2014 -โ‚น0.77 Billion-47.94%
2013 -โ‚น1.48 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น65.22 Billion 13,039.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น201.81 Billion 40,558.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-โ‚น1.97 Billion 295.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.51 Billion 2.45%๐Ÿ‡บ๐Ÿ‡ธ USA